Thermo Fisher Scientific Inc (TMO)
595.30
-1.85
(-0.31%)
USD |
NYSE |
May 17, 16:00
595.32
+0.02
(+0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Cash from Investing (Quarterly): -2.03B for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.03B |
| December 31, 2023 | -376.00M |
| September 30, 2023 | -1.181B |
| June 30, 2023 | -443.00M |
| March 31, 2023 | -3.142B |
| December 31, 2022 | -525.00M |
| September 30, 2022 | -545.00M |
| June 30, 2022 | -419.00M |
| March 31, 2022 | -670.00M |
| December 31, 2021 | -18.69B |
| September 30, 2021 | -616.00M |
| June 30, 2021 | -626.00M |
| March 31, 2021 | -1.998B |
| December 31, 2020 | -626.00M |
| September 30, 2020 | -365.00M |
| June 30, 2020 | -259.00M |
| March 31, 2020 | -260.00M |
| December 31, 2019 | -339.00M |
| September 30, 2019 | -198.00M |
| June 30, 2019 | -769.00M |
| March 31, 2019 | -181.00M |
| December 31, 2018 | -721.00M |
| September 30, 2018 | -168.00M |
| June 30, 2018 | -185.00M |
| March 31, 2018 | -179.00M |
| Date | Value |
|---|---|
| December 31, 2017 | -283.00M |
| September 30, 2017 | -6.969B |
| June 30, 2017 | -95.00M |
| March 31, 2017 | -382.00M |
| December 31, 2016 | -92.10M |
| September 30, 2016 | -4.193B |
| June 30, 2016 | -96.40M |
| March 31, 2016 | -1.139B |
| December 31, 2015 | -517.00M |
| September 30, 2015 | -106.70M |
| June 30, 2015 | -75.00M |
| March 31, 2015 | -394.30M |
| December 31, 2014 | -126.00M |
| September 30, 2014 | 417.40M |
| June 30, 2014 | -6.20M |
| March 31, 2014 | -12.07B |
| December 31, 2013 | -70.00M |
| September 30, 2013 | -60.40M |
| June 30, 2013 | -65.70M |
| March 31, 2013 | -67.20M |
| December 31, 2012 | -70.80M |
| September 30, 2012 | -995.40M |
| June 30, 2012 | -238.50M |
| March 31, 2012 | -66.20M |
| December 31, 2011 | -72.80M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-18.69B
Minimum
Dec 2021
-198.00M
Maximum
Sep 2019
-1.704B
Average
-580.50M
Median
Cash from Investing (Quarterly) Benchmarks
| Fonar Corp | -0.289M |
| XWELL Inc | 6.822M |
| ProPhase Labs Inc | 2.435M |
| Applied DNA Sciences Inc | -0.0148M |
| Veracyte Inc | 2.878M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.251B |
| Cash from Financing (Quarterly) | -1.821B |
| Free Cash Flow | 7.56B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 213.00M |
| Free Cash Flow to Firm (Quarterly) | 973.15M |
| Free Cash Flow Yield | 3.28% |